BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19443274)

  • 1. Pediatric renal cell carcinoma.
    Sausville JE; Hernandez DJ; Argani P; Gearhart JP
    J Pediatr Urol; 2009 Aug; 5(4):308-14. PubMed ID: 19443274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
    Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
    Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma in children and adolescents.
    Spreafico F; Collini P; Terenziani M; Marchianò A; Piva L
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1967-78. PubMed ID: 21110762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy.
    Rais-Bahrami S; Drabick JJ; De Marzo AM; Hicks J; Ho C; Caroe AE; Argani P
    Urology; 2007 Jul; 70(1):178.e3-6. PubMed ID: 17656236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
    Kunthur A; Wiernik PH; Dutcher JP
    Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation carcinomas of the kidney after chemotherapy in childhood.
    Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
    J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature.
    Schafernak KT; Yang XJ; Hsueh W; Leestma JL; Stagl J; Goldman S
    Can J Urol; 2007 Dec; 14(6):3739-44. PubMed ID: 18163925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.
    Hedgepeth RC; Zhou M; Ross J
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):602-4. PubMed ID: 19636262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
    Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
    Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma: Children's Hospital Boston experience.
    Estrada CR; Suthar AM; Eaton SH; Cilento BG
    Urology; 2005 Dec; 66(6):1296-300. PubMed ID: 16360460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic investigation of kidney tumors. A supplement to conventional diagnosis].
    Pedersen RK; Kerndrup GB
    Ugeskr Laeger; 1999 Aug; 161(31):4376-9. PubMed ID: 10487099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of renal cell carcinoma after successful treatment of Wilms tumor.
    Rich BS; McEvoy MP; La Quaglia MP
    J Pediatr Surg; 2010 Sep; 45(9):1883-6. PubMed ID: 20850637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
    Smaldone MC; Fung C; Uzzo RG; Haas NB
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma as second malignancy in patient with previous Wilms tumor.
    Lazarus J; Moolman C
    Urology; 2009 Sep; 74(3):598-600. PubMed ID: 19523667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
    Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
    Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing family of hereditary renal cell carcinoma.
    Richard S; Lidereau R; Giraud S
    Nephrol Dial Transplant; 2004 Dec; 19(12):2954-8. PubMed ID: 15507478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.